LecTec
This article was originally published in The Tan Sheet
Executive Summary
Minnetonka, Minn. firm to "aggressively execute" OTC topical drug delivery strategy following $7.2 mil. cash deal to sell its diagnostic electrode and electrically conductive adhesive hydrogel business to Tyco Healthcare subsidiary The Ludlow Company, the firm announces Nov. 21. The sale "represents a significant step in our re-invention process," LecTec says. The deal is expected to close in January
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning